ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Subtype	Biosample Name	Biosample Description	Species	Strain	Cancer Type	Tissue	Cell Type	Cell Line	Treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446796	GSE75313	None	GSM1949045	Melanoma	Cutaneous Melanoma (SKCM)	Pt1 baseline	Patient 1 melanoma, pre MAPKi treatment, 1st biopsy	Homo sapiens	Pt1 baseline	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446797	GSE75313	None	GSM1949046	Melanoma	Cutaneous Melanoma (SKCM)	Pt1 D85	Patient 1 melanoma, during BRAFi treatment, day 85, 1st biopsy	Homo sapiens	Pt1 D85	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446798	GSE75313	None	GSM1949047	Melanoma	Cutaneous Melanoma (SKCM)	Pt2 baseline	Patient 2 melanoma, pre MAPKi treatment, 1st biopsy	Homo sapiens	Pt2 baseline	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446799	GSE75313	None	GSM1949048	Melanoma	Cutaneous Melanoma (SKCM)	Pt2 D726	Patient 2 melanoma, during BRAFi treatment, day 726, 1st biopsy	Homo sapiens	Pt2 D726	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446800	GSE75313	None	GSM1949049	Melanoma	Cutaneous Melanoma (SKCM)	Pt3 baseline	Patient 3 melanoma, pre MAPKi treatment, 1st biopsy	Homo sapiens	Pt3 baseline	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446801	GSE75313	None	GSM1949050	Melanoma	Cutaneous Melanoma (SKCM)	Pt3 D22	Patient 3 melanoma, during BRAFi and MEKi treatment, day 22, 1st biopsy	Homo sapiens	Pt3 D22	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446802	GSE75313	None	GSM1949051	Melanoma	Cutaneous Melanoma (SKCM)	Pt4 baseline	Patient 4 melanoma, pre MAPKi treatment, 1st biopsy	Homo sapiens	Pt4 baseline	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM1949052	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446804	GSE75313	None	GSM1949053	Melanoma	Cutaneous Melanoma (SKCM)	Pt4 RD261	Patient 4 melanoma, during BRAFi and MEKi treatment, day 261, 1st biopsy	Homo sapiens	Pt4 RD261	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446805	GSE75313	None	GSM1949054	Melanoma	Cutaneous Melanoma (SKCM)	Pt6 baseline	Patient 6 melanoma, pre MAPKi treatment, 1st biopsy	Homo sapiens	Pt6 baseline	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446806	GSE75313	None	GSM1949055	Melanoma	Cutaneous Melanoma (SKCM)	Pt6 D6	Patient 6 melanoma, during BRAFi treatment, day 15, 1st biopsy	Homo sapiens	Pt6 D6	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM1949056	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446808	GSE75313	None	GSM1949057	Melanoma	Cutaneous Melanoma (SKCM)	Pt6 D15	Patient 6 melanoma, during BRAFi and MEKi treatment, day 15 (using a combination of two different BRAFi and MEKi), 1st biopsy	Homo sapiens	Pt6 D15	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446809	GSE75313	None	GSM1949058	Melanoma	Cutaneous Melanoma (SKCM)	Pt7 baseline	Patient 7 melanoma, pre MAPKi treatment, 1st biopsy	Homo sapiens	Pt7 baseline	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446810	GSE75313	None	GSM1949059	Melanoma	Cutaneous Melanoma (SKCM)	Pt7 D15A	Patient 7 melanoma, during MEKi treatment, day 15, 1st biopsy	Homo sapiens	Pt7 D15A	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446811	GSE75313	None	GSM1949060	Melanoma	Cutaneous Melanoma (SKCM)	Pt7 D15B	Patient 7 melanoma, during MEKi treatment, day 15, 2nd biopsy	Homo sapiens	Pt7 D15B	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446812	GSE75313	None	GSM1949061	Melanoma	Cutaneous Melanoma (SKCM)	Pt7 D15C	Patient 7 melanoma, during MEKi treatment, day 15, 3rd biopsy	Homo sapiens	Pt7 D15C	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM1949062	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446814	GSE75313	None	GSM1949063	Melanoma	Cutaneous Melanoma (SKCM)	Pt8 D22	Patient 8 melanoma, during BRAFi and MEKi treatment, day 22, 1st biopsy	Homo sapiens	Pt8 D22	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446815	GSE75313	None	GSM1949064	Melanoma	Cutaneous Melanoma (SKCM)	M229-P-1	Melanoma cell line M229, parental, MAPKi sensitive, DMSO treated for 2 days, Rep 1	Homo sapiens	M229-P-1	Melanoma	None	None	M229	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446816	GSE75313	None	GSM1949065	Melanoma	Cutaneous Melanoma (SKCM)	M229-P-2	Melanoma cell line M229, parental, MAPKi sensitive, DMSO treated for 2 days, Rep 2	Homo sapiens	M229-P-2	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446817	GSE75313	None	GSM1949066	Melanoma	Cutaneous Melanoma (SKCM)	M229-BRAFi2D-1	Melanoma cell line M229, treated with BRAFi for 2 days, Rep 1	Homo sapiens	M229-BRAFi2D-1	Melanoma	None	None	M229	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446818	GSE75313	None	GSM1949067	Melanoma	Cutaneous Melanoma (SKCM)	M229-BRAFi2D-2	Melanoma cell line M229, treated with BRAFi  for 2 days, Rep 2	Homo sapiens	M229-BRAFi2D-2	Melanoma	None	None	M229	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM1949068	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M229	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446820	GSE75313	None	GSM1949069	Melanoma	Cutaneous Melanoma (SKCM)	M229-DTP-2	Melanoma cell line M229, treated with BRAFi , DTP population, Rep 2	Homo sapiens	M229-DTP-2	Melanoma	None	None	M229	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446821	GSE75313	None	GSM1949070	Melanoma	Cutaneous Melanoma (SKCM)	M229-DTPP-1	Melanoma cell line M229, treated with BRAFi , DTPP population, Rep 1	Homo sapiens	M229-DTPP-1	Melanoma	None	None	M229	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446822	GSE75313	None	GSM1949071	Melanoma	Cutaneous Melanoma (SKCM)	M229-DTPP-2	Melanoma cell line M229, treated with BRAFi , DTPP population, Rep 2	Homo sapiens	M229-DTPP-2	Melanoma	None	None	M229	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446823	GSE75313	None	GSM1949072	Melanoma	Cutaneous Melanoma (SKCM)	M229-SDR-1	Melanoma cell line M229R5, BRAFi resistant  subline of M229 (clone R5), Rep 1	Homo sapiens	M229-SDR-1	Melanoma	None	None	M229	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446824	GSE75313	None	GSM1949073	Melanoma	Cutaneous Melanoma (SKCM)	M229-SDR-2	Melanoma cell line M229R5, BRAFi resistant  subline of M229 (clone R5), Rep 2	Homo sapiens	M229-SDR-2	Melanoma	None	None	M229	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM1949074	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M238	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446826	GSE75313	None	GSM1949075	Melanoma	Cutaneous Melanoma (SKCM)	M238-P-2	Melanoma cell line M238, parental, MAPKi sensitive, DMSO treated for 2 days, Rep 2	Homo sapiens	M238-P-2	Melanoma	None	None	M238	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446827	GSE75313	None	GSM1949076	Melanoma	Cutaneous Melanoma (SKCM)	M238-BRAFi2D-1	Melanoma cell line M238, treated with BRAFi  for 2 days, Rep 1	Homo sapiens	M238-BRAFi2D-1	Melanoma	None	None	M238	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446828	GSE75313	None	GSM1949077	Melanoma	Cutaneous Melanoma (SKCM)	M238-BRAFi2D-2	Melanoma cell line M238, treated with BRAFi  for 2 days, Rep 2	Homo sapiens	M238-BRAFi2D-2	Melanoma	None	None	M238	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446829	GSE75313	None	GSM1949078	Melanoma	Cutaneous Melanoma (SKCM)	M238-DTP-1	Melanoma cell line M238, treated with BRAFi , DTP population, Rep 1	Homo sapiens	M238-DTP-1	Melanoma	None	None	M238	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446830	GSE75313	None	GSM1949079	Melanoma	Cutaneous Melanoma (SKCM)	M238-DTP-2	Melanoma cell line M238, treated with BRAFi , DTP population, Rep 2	Homo sapiens	M238-DTP-2	Melanoma	None	None	M238	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446831	GSE75313	None	GSM1949080	Melanoma	Cutaneous Melanoma (SKCM)	M238-DTPP-1	Melanoma cell line M238, treated with BRAFi , DTPP population, Rep 1	Homo sapiens	M238-DTPP-1	Melanoma	None	None	M238	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446832	GSE75313	None	GSM1949081	Melanoma	Cutaneous Melanoma (SKCM)	M238-DTPP-2	Melanoma cell line M238, treated with BRAFi , DTPP population, Rep 2	Homo sapiens	M238-DTPP-2	Melanoma	None	None	M238	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446833	GSE75313	None	GSM1949082	Melanoma	Cutaneous Melanoma (SKCM)	M238-SDR-1	Melanoma cell line M238R1, BRAFi resistant  subline of M238 (clone R1), Rep 1	Homo sapiens	M238-SDR-1	Melanoma	None	None	M238	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX1446834	GSE75313	None	GSM1949083	Melanoma	Cutaneous Melanoma (SKCM)	M238-SDR-2	Melanoma cell line M238R1, BRAFi resistant  subline of M238 (clone R1), Rep 2	Homo sapiens	M238-SDR-2	Melanoma	None	None	M238	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3171019	GSE75313	None	GSM2776941	Melanoma	Cutaneous Melanoma (SKCM)	M263 P	Melanoma cell line M263, parental, MAPKi sensitive, DMSO treated for 2 days	Homo sapiens	M263 P	Melanoma	None	None	M263	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3171020	GSE75313	None	GSM2776942	Melanoma	Cutaneous Melanoma (SKCM)	M263 SDR	Melanoma cell line M263, BRAFi resistant (PLX4320 1uM) subline of M263 (clone R3)	Homo sapiens	M263 SDR	Melanoma	None	None	M263	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3171021	GSE75313	None	GSM2776943	Melanoma	Cutaneous Melanoma (SKCM)	M395 P1	Melanoma cell line M395, parental, MAPKi sensitive, DMSO treated for 2 days	Homo sapiens	M395 P1	Melanoma	None	None	M395	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3171022	GSE75313	None	GSM2776944	Melanoma	Cutaneous Melanoma (SKCM)	M395 SDR1	Melanoma cell line M395, BRAFi resistant (PLX4320 1uM) subline of M395	Homo sapiens	M395 SDR1	Melanoma	None	None	M395	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3171023	GSE75313	None	GSM2776945	Melanoma	Cutaneous Melanoma (SKCM)	M395 P2	Melanoma cell line M395, parental, MAPKi sensitive, DMSO treated for 2 days  (developed separately at Ribas lab)	Homo sapiens	M395 P2	Melanoma	None	None	M395	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3171024	GSE75313	None	GSM2776946	Melanoma	Cutaneous Melanoma (SKCM)	M395 SDR2	Melanoma cell line M395, BRAFi resistant (PLX4320 1uM) subline of M395 (developed separately at Ribas lab)	Homo sapiens	M395 SDR2	Melanoma	None	None	M395	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3171025	GSE75313	None	GSM2776947	Melanoma	Cutaneous Melanoma (SKCM)	M397 P1	Melanoma cell line M397, parental, MAPKi sensitive, DMSO treated for 2 days	Homo sapiens	M397 P1	Melanoma	None	None	M397	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2776948	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M397	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178218	GSE75313	Y1.7-Veh	GSM2779776	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Veh1	YUMM1.7 melanoma tumor, pre BRAFi treatment, 1st tumor	Mus musculus	Y1.7-Veh1	Melanoma	tumor biopsy	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178219	GSE75313	Y1.7-Veh	GSM2779777	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Veh2	YUMM1.7 melanoma tumor, pre BRAFi treatment, 2nd tumor	Mus musculus	Y1.7-Veh2	Melanoma	tumor biopsy	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178220	GSE75313	Y1.7-Veh	GSM2779778	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Veh3	YUMM1.7 melanoma tumor, pre BRAFi treatment, 3rd tumor	Mus musculus	Y1.7-Veh3	Melanoma	tumor biopsy	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178221	GSE75313	Y1.7-Veh	GSM2779779	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Veh4	YUMM1.7 melanoma tumor, pre BRAFi treatment, 4th tumor	Mus musculus	Y1.7-Veh4	Melanoma	tumor biopsy	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178222	GSE75313	Y1.7-Reg	GSM2779780	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Reg-1	YUMM1.7 melanoma tumor, on BRAFi treatment, regressing, 1st tumor	Mus musculus	Y1.7-Reg-1	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178223	GSE75313	Y1.7-Reg	GSM2779781	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Reg-2	YUMM1.7 melanoma tumor, on BRAFi treatment, regressing, 2nd tumor	Mus musculus	Y1.7-Reg-2	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178224	GSE75313	Y1.7-Reg	GSM2779782	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Reg-3	YUMM1.7 melanoma tumor, on BRAFi treatment, regressing, 3rd tumor	Mus musculus	Y1.7-Reg-3	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178225	GSE75313	Y1.7-Reg	GSM2779783	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Reg-4	YUMM1.7 melanoma tumor, on BRAFi treatment, regressing, 4th tumor	Mus musculus	Y1.7-Reg-4	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178226	GSE75313	Y1.7-Res	GSM2779784	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Res-1	YUMM1.7 melanoma tumor, on BRAFi treatment, residual/cytostatic, 1st tumor	Mus musculus	Y1.7-Res-1	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178227	GSE75313	Y1.7-Res	GSM2779785	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Res-2	YUMM1.7 melanoma tumor, on BRAFi treatment, residual/cytostatic, 2nd tumor	Mus musculus	Y1.7-Res-2	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178228	GSE75313	Y1.7-Res	GSM2779786	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Res-3	YUMM1.7 melanoma tumor, on BRAFi treatment, residual/cytostatic, 3rd tumor	Mus musculus	Y1.7-Res-3	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178229	GSE75313	Y1.7-Res	GSM2779787	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Res-4	YUMM1.7 melanoma tumor, on BRAFi treatment, residual/cytostatic, 4th tumor	Mus musculus	Y1.7-Res-4	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178230	GSE75313	Y1.7-Res	GSM2779788	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Res-5	YUMM1.7 melanoma tumor, on BRAFi treatment, residual/cytostatic, 5th tumor	Mus musculus	Y1.7-Res-5	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178231	GSE75313	Y1.7-Prog	GSM2779789	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Prog-1	YUMM1.7 melanoma tumor, BRAFi resistant, 1st tumor	Mus musculus	Y1.7-Prog-1	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178232	GSE75313	Y1.7-Prog	GSM2779790	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Prog-2	YUMM1.7 melanoma tumor, BRAFi resistant, 2nd tumor	Mus musculus	Y1.7-Prog-2	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178233	GSE75313	Y1.7-Prog	GSM2779791	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Prog-3	YUMM1.7 melanoma tumor, BRAFi resistant, 3rd tumor	Mus musculus	Y1.7-Prog-3	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178234	GSE75313	Y1.7-Prog	GSM2779792	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Prog-4	YUMM1.7 melanoma tumor, BRAFi resistant, 4th tumor	Mus musculus	Y1.7-Prog-4	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178235	GSE75313	Y1.7-Prog	GSM2779793	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-Prog-5	YUMM1.7 melanoma tumor, BRAFi resistant, 5th tumor	Mus musculus	Y1.7-Prog-5	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178236	GSE75313	Y1.7-BRAFi-Prog	GSM2779794	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-BRAFi-Prog-1	YUMM1.7 melanoma tumor, BRAFi resistant, 1st tumor (batch 2)	Mus musculus	Y1.7-BRAFi-Prog-1	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178237	GSE75313	Y1.7-BRAFi-Prog	GSM2779795	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-BRAFi-Prog-2	YUMM1.7 melanoma tumor, BRAFi resistant, 2nd tumor  (batch 2)	Mus musculus	Y1.7-BRAFi-Prog-2	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178238	GSE75313	Y1.7-BRAFi-Prog	GSM2779796	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-BRAFi-Prog-3	YUMM1.7 melanoma tumor, BRAFi resistant, 3rd tumor  (batch 2)	Mus musculus	Y1.7-BRAFi-Prog-3	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178239	GSE75313	Y1.7-BRAFi-aPDL2-small	GSM2779797	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-BRAFi-aPDL2-small-1	YUMM1.7 melanoma tumor, on BRAFi+aPD-L2 treatment, residual, 1st tumor (batch 2)	Mus musculus	Y1.7-BRAFi-aPDL2-small-1	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178240	GSE75313	Y1.7-BRAFi-aPDL2-small	GSM2779798	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-BRAFi-aPDL2-small-2	YUMM1.7 melanoma tumor, on BRAFi+aPD-L2 treatment, residual, 2nd tumor (batch 2)	Mus musculus	Y1.7-BRAFi-aPDL2-small-2	Melanoma	tumor biopsy	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178241	GSE75313	Y1.7-BRAFi-aPDL2-large	GSM2779799	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-BRAFi-aPDL2-large-1	YUMM1.7 melanoma tumor, BRAFi+aPD-L2 resistant, 1st tumor (batch 2)	Mus musculus	Y1.7-BRAFi-aPDL2-large-1	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	SRX3178242	GSE75313	Y1.7-BRAFi-aPDL2-large	GSM2779800	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-BRAFi-aPDL2-large-2	YUMM1.7 melanoma tumor, BRAFi+aPD-L2 resistant, 2nd tumor (batch 2)	Mus musculus	Y1.7-BRAFi-aPDL2-large-2	Melanoma	tumor biopsy	None	None	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2778479	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	None	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2778480	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2778481	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	None	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779261	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M397	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779263	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M397	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779264	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M397	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779265	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	SKMEL28	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779266	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	SKMEL28	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779267	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	SKMEL28	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779268	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	SKMEL28	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779269	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M249	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779270	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M249	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779271	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M249	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779272	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M249	mapki resistant
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779273	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M395	mapki none
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779275	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M395	mapki on-treatment
GSE75313	28864476	Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment	None	None	GSE75313	None	GSM2779276	Melanoma	Cutaneous Melanoma (SKCM)	None	None	Homo sapiens	None	Melanoma	None	None	M395	mapki resistant
